Warren Averett Asset Management, LLC Pfizer Inc Transaction History

Warren Averett Asset Management, LLC

$6.36 Billion
Q4 2024

A detailed history of Warren Averett Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 91,505 shares of PFE stock, worth $2.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

91,505

Previous 149,350 38.73%

Holding current value

$2.39 Million

Previous $4.32 Million 43.85%

% of portfolio

0.04%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $1.43 Million - $1.75 Million	-57,845 Reduced 38.73%	91,505 $2.43 Million
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $603,333 - $683,705	-21,781 Reduced 12.73%	149,350 $4.32 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $134,130 - $157,176	5,310 Added 3.2%	171,131 $4.79 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $1.14 Million - $1.31 Million	44,118 Added 36.25%	165,821 $4.6 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $70,551 - $91,638	-2,700 Reduced 2.17%	121,703 $3.5 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $70,116 - $81,959	-2,185 Reduced 1.73%	124,403 $4.13 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $3.29 Million - $3.8 Million	91,007 Added 255.77%	126,588 $4.64 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $814,348 - $1.06 Million	-20,674 Reduced 36.75%	35,581 $1.45 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $69,931 - $91,287	1,675 Added 3.07%	56,255 $2.88 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.59 Million - $1.94 Million	36,274 Added 198.15%	54,580 $2.39 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $43,645 - $51,749	938 Added 5.4%	18,306 $960,000
Q1 2022 May 17, 2022	SELL	$45.75 - $56.69 $26,809 - $33,220	-586 Reduced 3.26%	17,368 $899,000
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $35,700 - $52,920	-864 Reduced 4.59%	17,954 $912,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $205,670 - $264,200	5,240 Added 38.59%	18,818 $945,000
Q2 2021 Aug 17, 2021	SELL	$35.91 - $40.68 $21,150 - $23,960	-589 Reduced 4.16%	13,578 $658,000
Q1 2021 May 24, 2021	BUY	$33.49 - $37.77 $84,227 - $94,991	2,515 Added 21.58%	14,167 $568,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $35,344 - $44,943	-1,056 Reduced 8.31%	11,652 $401,000
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $12,858 - $15,086	405 Added 3.29%	12,708 $451,000
Q2 2020 Aug 17, 2020	BUY	$30.12 - $36.54 $4,879 - $5,919	162 Added 1.33%	12,303 $470,000
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $31,976 - $45,687	1,183 Added 10.8%	12,141 $396,000
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $23,142 - $26,264	-703 Reduced 6.03%	10,958 $419,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $22,320 - $28,943	687 Added 6.26%	11,661 $419,000
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $87,161 - $97,862	-2,357 Reduced 17.68%	10,974 $475,000
Q1 2019 May 06, 2019	BUY	$37.5 - $41.2 $28,687 - $31,518	765 Added 6.09%	13,331 $566,000
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $650,027 - $741,102	-16,897 Reduced 57.35%	12,566 $549,000
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $6,894 - $8,362	-200 Reduced 0.67%	29,463 $1.3 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $3,034 - $3,234	92 Added 0.31%	29,663 $1.08 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $217,466 - $252,291	-6,815 Reduced 18.73%	29,571 $1.05 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $330,205 - $350,359	9,928 Added 37.52%	36,386 $1.32 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $820,198 - $903,540	26,458	26,458 $945,000

Others Institutions Holding PFE

# of Institutions

3,359

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $146B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Warren Averett Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warren Averett Asset Management, LLC with notifications on news.

Account

Warren Averett Asset Management, LLC Pfizer Inc Transaction History